Haleon PLC
HLN
View Detailed Chart
10.310USD
-0.110-1.06%
Close 01/28, 16:00（ET）Quotes delayed by 15 min
92.63BMarket Cap
42.12P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.06%
5 Days
+0.68%
1 Month
+1.78%
6 Months
+6.29%
Year to Date
+1.98%
1 Year
+8.07%
View Detailed Chart
TradingKey Stock Score of Haleon PLC
Currency: USD Updated: 2026-01-28Key Insights
Haleon PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 45 out of 159 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 10.79.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Haleon PLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Haleon PLC Highlights
StrengthsRisks
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 8.92B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 41.40%.
Undervalued
The company’s latest PE is 42.12, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 543.06M shares, decreasing 6.66% quarter-over-quarter.
Held by Murray Stahl
Star Investor Murray Stahl holds 14.08K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.10.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
10.792
Target Price
+3.17%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Haleon PLC News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Haleon PLC Info
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
Ticker SymbolHLN
CompanyHaleon PLC
CEOMcnamara (Brian)
Websitehttps://www.haleon.com/
Related Instruments
-1.51%
+1.46%
-2.35%
-2.49%
-2.86%
-0.95%
-4.07%
-2.59%
-0.89%
-2.42%
+0.79%
-3.62%
-1.69%
-0.91%
-1.38%
-2.61%
0.00%
-2.42%
-1.30%Popular Symbols
256.440
-1.830 (-0.71%)
191.520
+3.000 (+1.59%)
88094.060
-1006.570 (-1.13%)
279.700
+27.040 (+10.70%)
2935.830
-73.870 (-2.45%)
431.460
+0.560 (+0.13%)
5531.840
+155.240 (+2.89%)
64.522
+1.305 (+2.06%)
1.196
+0.002 (+0.15%)
153.241
-0.136 (-0.09%)
